Clinical Trial Update: The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy in resectable squamous cell esophageal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Esophageal Cancer | Phase 3 | Status: RECRUITING